Teva Agrees to Pay $520M to Resolve Foreign-Bribery Claims

, The Legal Intelligencer


Generic drugmaker Teva Pharmaceutical Industries Ltd. has agreed to pay more than $283 million to resolve criminal charges and fines over bribes to government officials in Russia, Ukraine and Mexico, in violation of the Foreign Corrupt Practices Act, the U.S. Department of Justice announced Thursday.

This premium content is reserved for National Law Journal subscribers.

Continue reading by getting started with a subscription.

Already a subscriber? Log in now

What's being said

Comments are not moderated. To report offensive comments, click here.

Preparing comment abuse report for Article #1202775431948

Thank you!

This article's comments will be reviewed.